Covestor LTD Axogen, Inc. Transaction History

Covestor LTD

$181 Million
Q3 2025

A detailed history of Covestor LTD transactions in Axogen, Inc. stock. As of the latest transaction made, Covestor LTD holds 5 shares of AXGN stock, worth $118. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 5 -0.0%

Holding current value

$118

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$9.29 - $17.81 $46 - $89	5 New	5 $0
Q4 2023 Feb 09, 2024	BUY	$3.61 - $7.76 $0 - $0	0 New	0 $0
Q3 2023 Nov 13, 2023	BUY	$4.68 - $9.26 $0 - $0	0 New	0 $0

Others Institutions Holding AXGN

# of Institutions

186

Shares Held

41.6M

Call Options Held

86.4K

Put Options Held

14.3K

First Light Asset Management, LLC Edina, MN

5.81M
Shares

$137 Million
12.43% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$76.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.68M
Shares

$63.4 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.43M
Shares

$57.5 Million
0.0% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

1.96M
Shares

$46.3 Million
0.75% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $1B
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account